In the last trading session, 1.09 million shares of the NKGen Biotech Inc (NASDAQ:NKGN) were traded, and its beta was 0.48. Most recently the company’s share price was $0.35, and it changed around -$0.05 or -12.32% from the last close, which brings the market valuation of the company to $12.43M. NKGN currently trades at a discount to its 52-week high of $5.10, offering almost -1357.14% off that amount. The share price’s 52-week low was $0.20, which indicates that the current value has risen by an impressive 42.86% since then. We note from NKGen Biotech Inc’s average daily trading volume that its 10-day average is 5.06 million shares, with the 3-month average coming to 1.01 million.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

Instantly NKGN has showed a red trend with a performance of -12.32% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4480 on recent trading dayincreased the stock’s daily price by 21.88%. The company’s shares are currently down -87.27% year-to-date, but still down -22.43% over the last five days. On the other hand, NKGen Biotech Inc (NASDAQ:NKGN) is -12.81% down in the 30-day period. We can see from the shorts that 0.43 million shares have been sold at a short interest cover period of 1.14 day(s).

NKGN Dividends

NKGen Biotech Inc’s next quarterly earnings report is expected to be released in November.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 42.32% of NKGen Biotech Inc shares, and 10.03% of them are in the hands of institutional investors. The stock currently has a share float of 17.39%.